test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CYTKCytokinetics Inc
Recent Activity
Increased 375.42%
1.06%
$33.259M
629,906 shares@ $52.81 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
0.97%
$30.274M
1.235M shares@ $24.51 avg price
ANIPAni Pharmaceuticals Inc
Recent Activity
Increased 8.32%
0.96%
$30.118M
504,828 shares@ $59.66 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Decreased -43.07%
0.94%
$29.41M
1M shares@ $29.41 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Increased 490.47%
0.94%
$29.373M
1.101M shares@ $26.7 avg price
KYMRKymera Therapeutics Inc
Recent Activity
Decreased -59.97%
0.91%
$28.413M
600,326 shares@ $47.34 avg price
KRROKorro Bio Inc
Recent Activity
Increased 10.3%
0.91%
$28.407M
850,000 shares@ $33.42 avg price
RNAAvidity Biosciences Inc
Recent Activity
New Position
0.7%
$21.817M
475,000 shares@ $45.93 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
0.69%
$21.587M
1.35M shares@ $15.99 avg price
ALECAlector Inc
Recent Activity
0.69%
$21.585M
4.632M shares@ $4.67 avg price